White paper: Setting Priorities in Healthcare

Click

Leave your details and download the white paper!

{0} must be filled in.
{0} must be filled in.
This is your preferred e-mail where you will receive all communication from Vlerick Business School
{0} must be filled in.

You can - at any time - withdraw your consent of your personal data being used for the above-mentioned purpose(s) by sending an e-mail to [email protected]. Learn more about your rights and the use of your personal data in our privacy policy.

Healthcare management


Want to dive deeper into the world of healthcare innovation? Join senior professionals from health companies, hospitals and government on our Leading Innovation in Healthcare programme. Want to discover our other programmes in healthcare? Discover the portfolio!

Annelies Claeys

More info?

   
ANNELIES CLAEYS
Product Manager
[email protected]
T + 32 9 210 98 04 

Vlerick expertise in Healthcare Management

  1. European emergency health fund is needed to limit the impact of future crises

    The unprecedented public health crisis caused by COVID-19 overstretched the structures and mechanisms of the European Union, in particular those that deal with emergencies. There is a need for deeper union and collaboration across the European health care sector, as well as a need for a significant financial cushion for rapid and predictably increasing funding. In their new policy paper, Professor David Veredas, Professor Simon Ashby and doctoral researcher Dimitrios Kolokas propose the creation of an Emergency Health Financing Facility (EHFF), which would limit the impact of a future crisis on the EU and its member States.
  2. How to determine the hospital treatment costs for breast cancer patients?

    Healthcare costs are on the rise globally. And factors such as the increase in aging population, advancement in medical technology, and the current reimbursement system contribute to this rise. In addition, we see a lack of cost transparency and understanding centred around costs. A new study by doctoral researcher Erin Roman, Professor Brecht Cardoen and Professor Filip Roodhooft analyses the variability in treatment costs for breast cancer, using several patient and disease related factors, to better understand cost drivers.
All articles

Meet Us

Info Sessions & Open Days
02 Feb
Meet our programme advisor online
Category: General Info Sessions

01 Mar
Info Session Executive Education & MBA
Category: General Info Sessions

30 Mar
Experience Vlerick Over Lunch
Category: General Info Sessions

Accreditations
& Rankings

Equis Association of MBAs AACSB Financial Times